Aryl hydrocarbon hydroxylase is present and is inducible in mouse skin. 7,8-Benzoflavone, an inhibitor of the enzyme, markedly inhibits tumorigenesis by 7,12-dimethylbenz(a)anthracene, but has either no effect on or stimulates benzo(a)pyrene tumorigenesis. Thus, the role of aryl hydrocarbon hydroxylase appears highly specific for each polycyclic hydrocarbon, in respect to detoxification and/or activation of the hydrocarbon to a carcinogenic form. In parallel studies, we found that 7,8-benzoflavone significantly reduces the amount of 7,12-dimethylbenz(a)anthracene binding to mouse skin DNA, RNA, and protein, and the binding of benzo(a)pyrene to RNA and protein of mouse skin. 7,8-Benzoflavone exhibited a markedly lesser effect on the binding of benzo(a)-pyrene to DNA.
Polycyclic hydrocarbons are carcinogenic in various experimental animals and are known components of both cigarette smoke and polluted air. The major enzymes that metabolize polycyclic hydrocarbons are the microsomal mixed-function oxidases that also metabolize steroids and xenobiotics such as drugs, pesticides, and food additives (1, 2) . Aryl hydrocarbon hydroxylase converts polycyclic hydrocarbons to phenols, dihydrodiols, quinones, and epoxides (3) (4) (5) (6) (7) (8) (9) . The enzyme complex is present and is highly inducible in mouse skin (10) as well as in most mammalian tissues (4, 11, 12) and in some cells grown in culture (13) (14) (15) . Although the enzyme complex clearly functions as a detoxification agent (1, 2, 16) , we have suggested that this enzyme complex is also responsible for activation of polycyclic hydrocarbons to toxic and carcinogenic metabolites (10, (17) (18) (19) (20) (21) . This hypothesis is supported by the following: The amount of enzyme in various mammalian cells is positively correlated with susceptibility to benzo(a)pyrene cytotoxicity (19, 22, 23) . The enzyme catalyzes the formation of covalently bound complexes of hydrocarbon with DNA (17, 18, 24) , RNA (17, 18) , and protein (24) , and the binding of carcinogenic aminoazo dyes to protein (25) . A strong inhibitor of the enzyme, 7,8-benzoflavone (7, 26, 27) prevents the cytotoxicity of polycyclic hydrocarbons (26) and inhibits 7,12-dimethylbenz(a)anthracene (DMBA) tumorigenesis in mouse skin (10) .
DMBA is one of the most potent polycyclic-hydrocarbon carcinogens known, and benzo(a)pyrene is a major hydrocarbon component of smoke. In this paper, we study the role of the enzyme complex in induction of skin tumorigenesis by DMBA and benzo(a)pyrene by studying the effect of the aryl hydrocarbon hydroxylase inhibitor, 7,8-benzoflavone (10, 26, 27) on tumorigenesis and on the binding of the carcinogens to skin macromolecules. Preliminary results have been reported (28, 29 A single low dose of 100 nmol of DMBA applied to the backs of mice, followed by weekly application of croton oil, an essentially noncarcinogenic promoting agent, produces multiple tumors on the backs of the mice. In three experiments, 20 weeks after application of DMBA, the average number of tumors per mouse ranged from about 12 to 17 ( where it was applied twice weekly. In all experiments this treatment was followed by the weekly application of 1% croton oil. served a 40% inhibition of tumorigenesis in one experiment (Exp. 6) and essentially no inhibition in two other experiments (Exps. 4 and 7). In another experiment in which the benzo(a)pyrene was applied twice, at a 3-day interval, the 7,8-benzoflavone stimulated tumor formation by about 2-fold. Thus, although 7,8-benzoflavone is an effective inhibitor of DMBA initiation of tumorigenesis, it is essentially ineffective as inhibitor of benzo(a)pyrene-initiated tumorigenesis.
Tumorigenesis induced by repeated applications of DMBA or benzo(a)pyrene: effect of 7, 8-benzoflavone In three experiments, tumor formation caused by the repeated application of DMBA was inhibited by 74, 69, and 30% by the simultaneous application of 7,8-benzoflavone (Table 2 ). The effect of 7,8-benzoflavone on benzo(a)pyrene tumorigenesis was again markedly different from its effect on DMBA tumorigenesis. In three experiments, the 7,8-benzoflavone had either no effect (Exp. 6) or markedly stimulated tumor formation by benzo(a)pyrene. In two experiments, there was a 3-fold and 6-fold enhancement of tumor formation when 7,8-benzoflavone was applied simultaneously with the benzo(a)pyrene. 7,8-Benzoflavone alone was essentially nontumorigenic. The application of carcinogen and inhibitor in the experiments shown in Table 3 was similar to that described in the tumorigenesis experiment (Table 1 (3) (4) (5) (6) (7) (8) (9) . The complete profile of metabolite formation for each carcinogen by the control and induced enzyme complex is not known How this profile of metabolites is altered in the presence of 7,8-benzoflavone, the enzyme inhibitor, would seem most relevant to the interpretation of our results. It is likely that with DMBA, the 7,8-benzoflavone reduces the formation of the active carcinogenic form. With benzo(a)pyrene, the 7,8-benzoflavone may reduce the formation of detoxification products to a greater degree relative to the formation of the active carcinogenic form. This may in fact enhance the formation of the active form. Another possibility is that the enzyme complex for benzo(a)pyrene is primarily a detoxification system, and its inhibition increases the amount of nonenzymatic activation of the benzo(a)pyrene to an active carcinogenic form.
The number and nature of the reactive carcinogenic forms for each hydrocarbon have not been conclusively established. Some postulate that the reactive forms of the hydrocarbons are radical cations (39) or carbonium ions (40) . Several reports have demonstrated that microsomal enzymes catalyze the binding of polycyclic hydrocarbons to DNA (17, 18), RNA (17, 18) , and protein (24). Nagata et al. have reported that benzo(a)pyrene forms free radicals when mixed with skin homogenates (41). Lesko (7) found that 1:2,5: 6-dibenzanthracene undergoes epoxidation by the microsomal enzymes. Grover et al. (43) found that an epoxide of dibenz(ah)anthracene exhibits greater transforming activity on cells in culture than does the parent hydrocarbon. DiPaolo et al. (44) metabolism by either the induction or inhibition of the aryl hydrocarbon hydroxylase complex. The enzymes may uniquely detoxify or activate a specific hydrocarbon, and modification of the enzyme may yield different end products for each hydrocarbon, in respect to its ultimate carcinogenic activity.
The formation of polycyclic hydrocarbons that are covalently bound to macromolecules of mouse skin has been observed during tumorigenesis (46) (47) (48) (49) , although the relevancy of these bound forms to carcinogenesis remains to be clarified. Some correlative results suggest that these interactions may be important to polycyclic-hydrocarbon tumorigenesis. Binding of hydrocarbons to DNA may induce genetic changes, while binding to RNA or protein may induce epigenetic changes, leading to an altered gene expression that can characterize the tumor (2, 16, 50) . Thus, nmethylcholanthrene has been shown to alter genetic expression (51) . Inhibition of the aryl hydrocarbon hydroxylase complex with 7,8-benzoflavone reduces the amount of DMBA binding to DNA, RNA, and protein by about 50%. Similarly, the binding of benzo(a)pyrene to skin RNA and protein is inhibited to about the same extent. In contrast, the 7,8-benzoflavone exhibits a markedly lesser effect on the binding of benzo(a)pyrene to skin DNA. This suggests that the reactions involved in the binding of the benzo(a)pyrene to skin DNA mayhavea special character defined by their relative insensitivity to inhibition by 7,8-benzoflavone. The basis for the insensitivity is unknown but may relate to the loci of DNA and enzyme, the stability of the active intermediate, or the possibility of nonenzymatic reactions. Our findings also suggest that the binding of the hydrocarbon to DNA may be the interaction most relevant to carcinogenesis, since 7,8-benzoflavone has relatively little effect on both the binding of benzo(a)pyrene to DNA and on benzo(a)pyrene-initiated tumorigenesis.
Aryl hydrocarbon hydroxylase, is clearly the prime biological receptor for polycyclic hydrocarbons. Their metabolism, which may include both detoxification and activation reactions, is clearly of paramount importance to their activity as carcinogenic agents. In liver and other tissues examined, there are at least two forms of the enzyme (27) that can be distinguished by their sensitivity to 7,8-benzoflavone inhibition. The role of the enzyme complex in carcinogenesis may be influenced by various factors, such as the amount of each type of enzyme, the amount of basal and induced enzyme, the hydrocarbon concentration, the cofactor or inhibitor concentration, and the relative activity of enzymes related to the subsequent metabolism of the products of aryl hydrocarbon hydroxylase.
